Hederacoside C

CAS No. 14216-03-6

Hederacoside C( Kalopanaxsaponin B | Hederacoside C | Hederoside H1 )

Catalog No. M17289 CAS No. 14216-03-6

Hederacoside C is expectorant for Cold and cough relief, Bronchitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
10MG 29 In Stock
25MG 44 In Stock
50MG 60 In Stock
100MG 86 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hederacoside C
  • Note
    Research use only, not for human use.
  • Brief Description
    Hederacoside C is expectorant for Cold and cough relief, Bronchitis.
  • Description
    Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
  • In Vitro
    Western Blot Analysis Cell Line: Caco-2 Concentration:0.1, 1, 10 μM Incubation Time:1 h Result:Reduced the expression of p-p65/p65, p-JNK, p-ERK, and p-p38.RT-PCR Cell Line:RAW 264.7 Concentration:5, 10, 50 μg/mL Incubation Time:1 h Result:Reduced the expressions of IL-1β, IL-6, TNF-α, and IL-10.
  • In Vivo
    Animal Model:TNBS-induced colitis in rat Dosage:0.625, 1.25, 2.5 mg/kg Administration:i.p.Result:Decreased the levels of inflammatory cytokines, including TNF-α, IL-6, IL-1β, CXCL-1, CXCL-2, and CXCL-5.Reduced cell apoptosis in TNBS-induced colitis.Reduced Bax/Bcl-2 ratio, cleaved caspase 3, and p53 protein levels in a dose-dependent manner.
  • Synonyms
    Kalopanaxsaponin B | Hederacoside C | Hederoside H1
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    14216-03-6
  • Formula Weight
    1221.39
  • Molecular Formula
    C59H96O26
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (81.87 mM)
  • SMILES
    [C@@H]1([C@@H](OC[C@@H]([C@@H]1O)O)O[C@@H]1[C@]([C@H]2[C@@]([C@@H]3[C@]([C@]4(C(=CC3)[C@H]3[C@@](CC4)(CCC(C3)(C)C)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]3[C@@H]([C@H]([C@H](O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)[C@H](O3)CO)O)O)O)O)O)C)(CC2)C)(CC1)C)(CO)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O
  • Chemical Name
    Olean-12-en-28-oic acid, 3- ((2-O-(6-deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl)oxy)-23-hydroxy-, O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl ester, (3beta,4alpha)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kim JM, et al. Xenobiotica. 2013 Nov;43(11):985-92.;
molnova catalog
related products
  • Tecastemizole

    Tecastemizole is a selective antagonist of H1 receptor and a major metabolite of astemizole with anti-inflammatory effects.

  • Bicyclol

    Bicyclol(SY 801) is an anti-hepatitis drug. Oral administration of bicyclol normalizes the elevated serum transaminases (ALT, AST) by 50% in chronic viral hepatitis B and C, and also has a certain level of inhibiting HBV and HCV replication.

  • Rupatadine Fumarate

    Rupatadine is an inhibitor of PAFR and histamine (H1) receptor with Ki of 550 nM and 102 nM, respectively.